Novocure Ltd Stock
Your prediction
Novocure Ltd Stock
Novocure Ltd gained 0.770% compared to yesterday.
For the coming years our community has positive and negative things to say abot the Novocure Ltd stock. Criterium "Shareholder structure" gathered the most positive votes but regarding "EBIT growth" there were negative voices in the community.
Pros and Cons of Novocure Ltd in the next few years
Pros
?
S********** s********
?
B****
?
G***** c******* t* c**********
Cons
?
C******** o* t** e**********
?
M***** P*******
?
W********* I********* f** t** n*** y****
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Novocure Ltd vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Novocure Ltd | 0.770% | 14.171% | 9.802% | -52.333% | 12.660% | -85.794% | -90.872% |
| Ironwood Pharmaceuticals | 1.740% | -7.182% | 7.006% | -23.636% | 26.316% | -68.356% | -65.361% |
| Iovance Biotherapeutics Inc. | -5.370% | -2.096% | 9.900% | -66.279% | -11.404% | -63.286% | -95.001% |
| United Therapeutics | -1.460% | -0.707% | 1.226% | 18.248% | -1.428% | 71.708% | 203.022% |
News
Novocure: Steady Ahead of Key Milestones
Here's our initial take on Novocure's (NASDAQ: NVCR) fiscal 2025 second-quarter financial report.
Novocure reported no surprises in its latest quarter, with revenue up 6% for the year and both
